Position in ZYME
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,404,919
+$132,707 QoQ
Shares Held
56,107
+16.1% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 94.64416204751636.ToString("F0")%
Shared 0.ToString("F0")%
None 5.355837952483648.ToString("F0")%
Common Shares in ZYME Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Dana Investment Advisors, Inc. holds $35,335,939 across 12 Biotechnology names. ZYME ranks #7 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
69,234 | $13,822,568 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
8,397 | $6,487,858 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
26,379 | $4,458,578 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
59,756 | $1,944,460 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,197 | $1,673,533 | |
| 6 | TGTX |
Tg Therapeutics, Inc.
|
43,954 | $1,460,151 | |
| 7 | ZYME |
Zymeworks Inc.
This page
|
56,107 | $1,404,919 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
18,487 | $1,388,188 |
All Filings in ZYME
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,404,919 | 56,107 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,272,212 | 48,318 | Shares | Sole | 2026-02-05 | |
| No filing history on record for this holder in this stock. | ||||||